2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide

C27H41N5O10Si — CID 10603961

IUPAC2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide
SMILESCc1cn([C@H]2C[C@H](O)[C@@H](CNC(=O)C[C@@H]3[C@H](O)[C@@H](CO[Si](C)(C)C(C)(C)C)O[C@H]3n3ccc(=O)[nH]c3=O)O2)c(=O)[nH]c1=O
InChIInChI=1S/C27H41N5O10Si/c1-14-12-32(26(39)30-23(14)37)21-10-16(33)17(41-21)11-28-20(35)9-15-22(36)18(13-40-43(5,6)27(2,3)4)42-24(15)31-8-7-19(34)29-25(31)38/h7-8,12,15-18,21-22,24,33,36H,9-11,13H2,1-6H3,(H,28,35)(H,29,34,38)(H,30,37,39)/t15-,16+,17-,18-,21-,22+,24-/m1/s1
InChIKeyYHMLEHWJHIGHQL-VLYFKJDPSA-N
MW623.74 g/mol
LogP-0.55
Rot. Bonds9

About 2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide

2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide (PubChem CID 10603961) has the molecular formula C27H41N5O10Si and a molecular weight of 623.74 g/mol. Its IUPAC name is 2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide.

Molecular Properties

Compound Name2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide
PubChem CID10603961
Molecular FormulaC27H41N5O10Si
Molecular Weight623.74 g/mol
Exact Mass623.26
IUPAC Name2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide
SMILESCc1cn([C@H]2C[C@H](O)[C@@H](CNC(=O)C[C@@H]3[C@H](O)[C@@H](CO[Si](C)(C)C(C)(C)C)O[C@H]3n3ccc(=O)[nH]c3=O)O2)c(=O)[nH]c1=O
InChIInChI=1S/C27H41N5O10Si/c1-14-12-32(26(39)30-23(14)37)21-10-16(33)17(41-21)11-28-20(35)9-15-22(36)18(13-40-43(5,6)27(2,3)4)42-24(15)31-8-7-19(34)29-25(31)38/h7-8,12,15-18,21-22,24,33,36H,9-11,13H2,1-6H3,(H,28,35)(H,29,34,38)(H,30,37,39)/t15-,16+,17-,18-,21-,22+,24-/m1/s1
InChIKeyYHMLEHWJHIGHQL-VLYFKJDPSA-N
XLogP-0.55
TPSA206.97 Ų
H-Bond Donors5
H-Bond Acceptors12
Rotatable Bonds9
Heavy Atoms43
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500623.74
LogP ≤ 5-0.55
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide?
The IUPAC name of 2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide (CID 10603961) is 2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide.
What is the SMILES notation for 2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide?
The canonical SMILES for 2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide is Cc1cn([C@H]2C[C@H](O)[C@@H](CNC(=O)C[C@@H]3[C@H](O)[C@@H](CO[Si](C)(C)C(C)(C)C)O[C@H]3n3ccc(=O)[nH]c3=O)O2)c(=O)[nH]c1=O.
What is the InChIKey of 2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide?
The InChIKey is YHMLEHWJHIGHQL-VLYFKJDPSA-N. The full InChI is InChI=1S/C27H41N5O10Si/c1-14-12-32(26(39)30-23(14)37)21-10-16(33)17(41-21)11-28-20(35)9-15-22(36)18(13-40-43(5,6)27(2,3)4)42-24(15)31-8-7-19(34)29-25(31)38/h7-8,12,15-18,21-22,24,33,36H,9-11,13H2,1-6H3,(H,28,35)(H,29,34,38)(H,30,37,39)/t15-,16+,17-,18-,21-,22+,24-/m1/s1.
What are the key properties of 2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide?
2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide has a molecular weight of 623.74 g/mol, XLogP of -0.55, 9 rotatable bonds, 5 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(2R,3R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-3-yl]-N-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide is sourced from PubChem (CID 10603961), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).